TrialLeukemia2018

Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study.

Stephan Stilgenbauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.